Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for tissue oxygenation and healing of diabetic foot ulcers
2009-010418-31Phase 3Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of acetylcysteine in type 2 diabetes mellitus (T2DM) and diabetic foot ulcer (DFU), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Improvement of tissue oxygenation, Increase of nitric oxide (NO) bioavailability and 1 more. Started Mar 2009; status: active.
02
Drugs
acetylcysteine
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2009-010418-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010418-31.